APA (7th ed.) Citation

Reding, M. T., Pabinger, I., Holme, P. A., Poulsen, L., Negrier, C., Chalasani, P., . . . Lalezari, S. (2021). Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: Final results of the PROTECT VIII extension study. Haemophilia, 27(3), e347. https://doi.org/10.1111/hae.14297

Chicago Style (17th ed.) Citation

Reding, Mark T., et al. "Confirmed Long‐term Safety and Efficacy of Prophylactic Treatment with BAY 94–9027 in Severe Haemophilia A: Final Results of the PROTECT VIII Extension Study." Haemophilia 27, no. 3 (2021): e347. https://doi.org/10.1111/hae.14297.

MLA (9th ed.) Citation

Reding, Mark T., et al. "Confirmed Long‐term Safety and Efficacy of Prophylactic Treatment with BAY 94–9027 in Severe Haemophilia A: Final Results of the PROTECT VIII Extension Study." Haemophilia, vol. 27, no. 3, 2021, p. e347, https://doi.org/10.1111/hae.14297.